<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="0" ids="53199">Poly(amido amine)</z:chebi> (<z:chebi fb="0" ids="53199">PAMAM</z:chebi>) <z:chebi fb="0" ids="51338">dendrimers</z:chebi> have shown promise in oral drug delivery </plain></SENT>
<SENT sid="1" pm="."><plain>Conjugation of SN38 to <z:chebi fb="0" ids="53199">PAMAM</z:chebi> <z:chebi fb="0" ids="51338">dendrimers</z:chebi> has the potential to improve its oral absorption while minimizing gastrointestinal toxicity </plain></SENT>
<SENT sid="2" pm="."><plain>In this work we evaluated G3.5 PAMAM <z:chebi fb="0" ids="51338">dendrimer</z:chebi>-SN38 conjugates with <z:chebi fb="21" ids="35701">ester</z:chebi>-linked glycine and β-alanine spacers for their suitability in oral therapy of hepatic <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastases</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>G3.5-βAlanine-SN38 was mostly stable while G3.5-Glycine-SN38 showed 10%, 20%, and 56% SN38 release in simulated gastric, intestinal and liver environments for up to 6, 24 and 48 hours, respectively </plain></SENT>
<SENT sid="4" pm="."><plain>Short-term treatment of Caco-2 cells with G3.5-SN38 conjugates did not reduce cell viability, while comparable concentrations of SN38 caused significant cytotoxicity </plain></SENT>
<SENT sid="5" pm="."><plain>G3.5-Glycine-SN38 and G3.5-βAlanine-SN38 showed IC₅₀ values of 0.60 and 3.59 μM, respectively, in HT-29 cells treated for 48 h, indicating the efficacy of the drug delivery system in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> cells with longer incubation time </plain></SENT>
<SENT sid="6" pm="."><plain>Both conjugates increased SN38 transepithelial transport compared to the free drug </plain></SENT>
<SENT sid="7" pm="."><plain>Transport of G3.5-Glycine-SN38 was highly concentration-dependent whereas transport of G3.5-βAlanine-SN38 was concentration-independent, highlighting the influence of drug loading and spacer chemistry on transport mechanism </plain></SENT>
<SENT sid="8" pm="."><plain>Together these results show that <z:chebi fb="0" ids="53199">PAMAM</z:chebi> <z:chebi fb="0" ids="51338">dendrimers</z:chebi> have the potential to improve the oral bioavailability of potent anti-<z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> drugs </plain></SENT>
</text></document>